About This Amiodarone Infusion Rate Calculator
This Amiodarone Infusion Rate Calculator is designed for clinicians to prepare and administer an amiodarone infusion for managing stable tachyarrhythmias, such as atrial fibrillation with a rapid ventricular response (AFib with RVR). It quickly calculates the required infusion rates for the standard two-phase maintenance protocol, as well as the volume needed for the initial loading dose, based on any user-defined concentration. This tool helps ensure accurate dosing during a critical therapy.
The Formulas Explained
Step 1: Concentration
First, the concentration of the prepared infusion bag is determined. Standard concentrations are 1.8 mg/mL (e.g., 450mg in 250mL) or 1.5 mg/mL (e.g., 150mg in 100mL).
$$ \text{Concentration (mg/mL)} = \frac{\text{Total Amiodarone (mg)}}{\text{Total Diluent Volume (mL)}} $$
Step 2: Infusion Rates & Bolus Volume
The concentration is then used to calculate the volumetric rates (mL/hr) required to deliver the standard fixed doses, and the volume for the initial 150 mg bolus.
$$ \text{Rate (mL/hr)} = \frac{\text{Dose (mg/min)} \times 60 \text{ min/hr}}{\text{Concentration (mg/mL)}} $$
Clinical Interpretation & Limitations
The standard ACLS protocol for stable wide-complex tachycardia, often adapted for AFib with RVR, involves a multi-step infusion which this Amiodarone Infusion Rate Calculator is based on:
- Loading Dose: An initial 150 mg bolus is administered over 10 minutes to rapidly achieve therapeutic levels.
- Maintenance Infusion – Phase 1: An infusion at a rate of 1 mg/min is run for the first 6 hours.
- Maintenance Infusion – Phase 2: The rate is then reduced to 0.5 mg/min for the subsequent 18 hours.
Per the 2023 ACC/AHA atrial fibrillation guideline, the first-line agents for acute rate control are a beta-blocker or a non-dihydropyridine calcium channel blocker; IV amiodarone is reserved for patients with HFrEF or when first-line agents fail or are not tolerated, in part because of its acute rhythm-conversion risk and extensive long-term toxicity profile.
Limitations: This calculator is for informational purposes only and is intended for the standard AFib with RVR protocol. It should not be used for other indications like cardiac arrest, which requires a rapid IV push. All calculations must be confirmed according to institutional protocols. The user must exercise clinical judgment, as patient response and stability can vary.
Frequently Asked Questions (FAQ)
1. Why must amiodarone be given in D5W?
Amiodarone can precipitate (form solid particles) when mixed in sodium chloride (normal saline) solutions, especially at higher concentrations. D5W provides a stable medium for the infusion, preventing this dangerous complication.
2. Why is an in-line filter necessary?
The amiodarone formulation contains polysorbate 80, which can cause foaming and has been associated with the leaching of plasticizers (DEHP) from PVC bags and tubing. A 0.22 micron filter is recommended to mitigate these risks and filter any potential precipitates.
3. Can I give the loading dose faster than 10 minutes?
No. Rapid infusion of amiodarone can cause severe hypotension and bradycardia due to its vasodilatory and negative inotropic effects. The 10-minute administration time is a critical safety measure.
4. What should be done after the 24-hour infusion is complete?
Typically, the patient is transitioned to an oral dose of amiodarone for long-term rhythm or rate control. The plan for this transition should be made in advance, considering amiodarone’s long half-life.
5. Can this Amiodarone Infusion Rate Calculator be used for cardiac arrest?
No. The ACLS protocol for pulseless VT/VF cardiac arrest involves a 300 mg rapid IV/IO push, followed by a second dose of 150 mg if needed. This calculator is designed for the slower infusion used in stable patients.
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.
